Similar Search Results

The economic consequences of US FDA new drug approvals : evidence from Taiwan pharmaceutical and biotech companies

Chen, Yong-Jie; Feng, Zhi-Yuan; Li, Yueh-Ping; Huang, … - In: Innovation: organization & management : IOM 23 (2021) 3, pp. 354-374

Persistent link: https://www.econbiz.de/10012649635

Technology, cooperation and stock market value : an event study of new partnership announcements in the biotechnology and pharmaceutical industries

Campart, Sandy; Pfister, Etienne - In: Economics of innovation and new technology 16 (2007) 1/2, pp. 31-49

Persistent link: https://www.econbiz.de/10003516293

Technological races and stock market value : evidence from the pharmaceutical industry

Campart, Sandy; Pfister, Etienne - In: Economics of innovation and new technology 23 (2014) 3/4, pp. 215-238

Persistent link: https://www.econbiz.de/10010407493

Course technologique et valeur boursière : une étude d'événements basée sur l'industrie pharmaceutique

Campart, Sandy; Pfister, Etienne - In: Revue économique : revue bimestrielle 59 (2008) 2, pp. 307-329

Persistent link: https://www.econbiz.de/10003662956

Product alliances, alliance networks, and shareholder value : evidence from the biopharmaceutical industry

Mani, Sudha; Luo, Xueming - In: International journal of research in marketing : IJRM ; … 32 (2015) 1, pp. 9-22

Persistent link: https://www.econbiz.de/10010517017

R&D progress, stock price volatility, and post-announcement drift : an empirical investigation into biotech firms

Xu, Bixia - In: Review of quantitative finance and accounting 26 (2006) 4, pp. 391-408

Persistent link: https://www.econbiz.de/10003322939

Essays in financial economics

Verter, Geoffrey - 2003

Persistent link: https://www.econbiz.de/10003384083

Investor reactions to new product development failure in the biotechnology industry

Bürger, Robin - 2010

This dissertation investigates important and cutting-edge issues surrounding new product development failure and its consequences for market values of innovation-driven firms. Although a substantial body of literature demonstrates that new product development failure harms some companies more...

Persistent link: https://www.econbiz.de/10009011656

Firm knowledge and market value in biotechnology

Nesta, Lionel; Saviotti, Pier Paolo - In: Industrial and corporate change 15 (2006) 4, pp. 625-652

Persistent link: https://www.econbiz.de/10003368860

A tale of two bubbles : a preliminary look at the US internet and biotechnology bubbles

Demers, Elizabeth; Joos, Philip - In: Modern concepts of the theory of the firm : managing …, (pp. 523-551). 2004

Persistent link: https://www.econbiz.de/10001802814

1
2
3
4
5
6
7
8
9
10
Next
Last